Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tina Skinner

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
International Journal for Parasitology. Drugs and Drug Resistance|July 23, 2015
Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasitesJessica A Engel, Amy J Jones, Vicky M Avery, et al.
Biochemistry|May 5, 2009
The M17 leucine aminopeptidase of the malaria parasite Plasmodium falciparum: importance of active site metal ions in the binding of substrates and inhibitorsSelma Maric, Sheila M Donnelly, Mark W Robinson, et al.
Experimental Parasitology|February 10, 2024
Activity of alkoxyamide-based histone deacetylase inhibitors against Plasmodium falciparum malaria parasitesWisam A Dawood, Gillian M Fisher, Franziska J M Kinnen, et al.
International Journal for Parasitology. Drugs and Drug Resistance|September 30, 2016
Erratum to "Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites" [Int. J. Parasitol. Drugs Drug Res. 5 (2015) 117-126]Jessica A Engel, Amy J Jones, Vicky M Avery, et al.
ACS Chemical Biology|October 2, 2013
Plasmodium gametocyte inhibition identified from a natural-product-based fragment libraryHoan Vu, Catherine Roullier, Marc Campitelli, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2012
Antimalarial activity of the anticancer histone deacetylase inhibitor SB939Subathdrage D M Sumanadasa, Christopher D Goodman, Andrew J Lucke, et al.
International Journal for Parasitology. Drugs and Drug Resistance|September 24, 2021
Histone deacetylase inhibitor AR-42 and achiral analogues kill malaria parasites in vitro and in miceMing Jang Chua, Jiahui Tng, Eva Hesping, et al.
BMJ Open|February 3, 2022
Evaluating a multicomponent survivorship programme for men with prostate cancer in Australia: a single cohort studyPatsy Yates, Rob Carter, Robyn Cockerell, et al.
Psycho-Oncology|May 13, 2021
An integrated multicomponent care model for men affected by prostate cancer: A feasibility study of TrueNTH AustraliaPatsy Yates, Rob Carter, Robyn Cockerell, et al.
Chemmedchem|January 22, 2019
Structure-Activity and Structure-Toxicity Relationships of Peptoid-Based Histone Deacetylase Inhibitors with Dual-Stage Antiplasmodial ActivityMarcel K W Mackwitz, Eva Hesping, Yevgeniya Antonova-Koch, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
International Journal for Parasitology. Drugs and Drug Resistance|July 23, 2015
Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasitesJessica A Engel, Amy J Jones, Vicky M Avery, et al.
Biochemistry|May 5, 2009
The M17 leucine aminopeptidase of the malaria parasite Plasmodium falciparum: importance of active site metal ions in the binding of substrates and inhibitorsSelma Maric, Sheila M Donnelly, Mark W Robinson, et al.
Experimental Parasitology|February 10, 2024
Activity of alkoxyamide-based histone deacetylase inhibitors against Plasmodium falciparum malaria parasitesWisam A Dawood, Gillian M Fisher, Franziska J M Kinnen, et al.
International Journal for Parasitology. Drugs and Drug Resistance|September 30, 2016
Erratum to "Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites" [Int. J. Parasitol. Drugs Drug Res. 5 (2015) 117-126]Jessica A Engel, Amy J Jones, Vicky M Avery, et al.
ACS Chemical Biology|October 2, 2013
Plasmodium gametocyte inhibition identified from a natural-product-based fragment libraryHoan Vu, Catherine Roullier, Marc Campitelli, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2012
Antimalarial activity of the anticancer histone deacetylase inhibitor SB939Subathdrage D M Sumanadasa, Christopher D Goodman, Andrew J Lucke, et al.
International Journal for Parasitology. Drugs and Drug Resistance|September 24, 2021
Histone deacetylase inhibitor AR-42 and achiral analogues kill malaria parasites in vitro and in miceMing Jang Chua, Jiahui Tng, Eva Hesping, et al.
BMJ Open|February 3, 2022
Evaluating a multicomponent survivorship programme for men with prostate cancer in Australia: a single cohort studyPatsy Yates, Rob Carter, Robyn Cockerell, et al.
Psycho-Oncology|May 13, 2021
An integrated multicomponent care model for men affected by prostate cancer: A feasibility study of TrueNTH AustraliaPatsy Yates, Rob Carter, Robyn Cockerell, et al.
Chemmedchem|January 22, 2019
Structure-Activity and Structure-Toxicity Relationships of Peptoid-Based Histone Deacetylase Inhibitors with Dual-Stage Antiplasmodial ActivityMarcel K W Mackwitz, Eva Hesping, Yevgeniya Antonova-Koch, et al.
Pageof 3